Presentation at the FDA’s Public Hearing Entitled “Standards for Future Opioid Analgesic Approvals and Incentives for New Therapeutics to Treat Pain and Addiction”
In its presentation at the Food and Drug Administration’s (FDA’s) public hearing on opioids, Public Citizen emphasized that had the FDA acted with the urgency demanded by the ongoing opioid crisis and begun the important public process of developing a desperately needed improved opioid regulatory framework soon after it received the detailed, carefully considered National Academies of Sciences, Engineering, and Medicine’s recommendations two years ago, it is likely that the process of creating this framework would have been completed by now, rather than just beginning.
See Public Citizen’s other work on opioid drug issues.